These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 6146299)

  • 21. [Plasmatic AMPc and GMPc changes in asthmatic patients induced by beta stimulation or blockade and methylcholine (author's transl)].
    Clauzel AM; Poulet P; Severac JC; Sanjuan B; Michel FB; Grenier J
    Nouv Presse Med; 1978 Apr; 7(15):1298. PubMed ID: 208056
    [No Abstract]   [Full Text] [Related]  

  • 22. Asthma: a modern perspective.
    Leffert F
    Pediatrics; 1978 Dec; 62(6):1061-9. PubMed ID: 32514
    [No Abstract]   [Full Text] [Related]  

  • 23. Interactions between beta-adrenergic activity and prostaglandin synthesis in control of airways bronchoconstrictor responsiveness.
    Walters EH
    Agents Actions Suppl; 1983; 13():189-93. PubMed ID: 6307019
    [No Abstract]   [Full Text] [Related]  

  • 24. [Broncholytic effect of terbutaline (Bricanyl) with reference to circulation reactions].
    Thiede D
    Med Klin; 1973 Jan; 68(1):16-20. PubMed ID: 4405484
    [No Abstract]   [Full Text] [Related]  

  • 25. Measurement of beta-adrenergic receptors on lymphocytes in normal subjects and asthmatics in relation to beta-adrenergic hyperglycaemic response and bronchial responsiveness.
    Motojima S; Fukuda T; Makino S
    Allergy; 1983 Jul; 38(5):331-7. PubMed ID: 6311042
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Metabolic and hormonal responses to salbutamol in asthma. Evidence of beta-adrenergic overactivity?
    Kallenbach JM; Panz VR; Jankelow D; Joffe BI; Seftel HC
    Respiration; 1990; 57(1):21-7. PubMed ID: 2163093
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of glucose tolerance status in patients with asthma bronchiale.
    Gulcan E; Bulut I; Toker A; Gulcan A
    J Asthma; 2009 Mar; 46(2):207-9. PubMed ID: 19253132
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cost-effectiveness of inhaled beta-agonists v. oral salbutamol in asthma: a randomized double-blind cross-over study.
    Thomas K; Peter JV; Cherian AM; Guyatt G
    Natl Med J India; 1996; 9(4):159-62. PubMed ID: 8772331
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Changes in the beta-adrenergic system in bronchial asthma induced by terbutaline.
    Koëter GH; Meurs H; Kauffman HF; de Monchy JG; Sluiter HJ; de Vries K
    Agents Actions Suppl; 1983; 13():259-64. PubMed ID: 6307021
    [No Abstract]   [Full Text] [Related]  

  • 30. [Beta-adrenergic receptors of the lymphocytes and bronchial hypersensitivity].
    Sakakibara H; Suetsugu S; Umeda H
    Nihon Kyobu Shikkan Gakkai Zasshi; 1984 May; 22(5):383-9. PubMed ID: 6092755
    [No Abstract]   [Full Text] [Related]  

  • 31. [Involvement of G proteins between receptors and KCa channels in the regulation of airway tone by the autonomic nervous system].
    Kume H; Takagi K
    Nihon Kyobu Shikkan Gakkai Zasshi; 1995 Dec; 33 Suppl():116-24. PubMed ID: 8752494
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Respiratory disease and clinical pharmacology--serum concentration and pharmacological effect of beta-stimulant and theophylline].
    Yamazaki K; Ohkawa K; Nakajima S
    Nihon Kyobu Shikkan Gakkai Zasshi; 1987 Jan; 25(1):14-9. PubMed ID: 3037143
    [No Abstract]   [Full Text] [Related]  

  • 33. Possible mechanisms in asthma.
    Butcher BT
    Eur J Respir Dis Suppl; 1982; 123():17-20. PubMed ID: 6297945
    [No Abstract]   [Full Text] [Related]  

  • 34. Slow-responders to IV beta2-adrenergic agonist therapy: defining a novel phenotype in pediatric asthma.
    Carroll CL; Schramm CM; Zucker AR
    Pediatr Pulmonol; 2008 Jul; 43(7):627-33. PubMed ID: 18500733
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Role of particulate matter and small airways in treatment of asthma with inhalative fixcombinations].
    Voshaar T
    Dtsch Med Wochenschr; 2009 Dec; 134 Suppl 10():S390-3. PubMed ID: 19941243
    [No Abstract]   [Full Text] [Related]  

  • 36. Correlation between terbutaline serum levels, c-AMP plasma levels and FEV1 in normals and asthmatics after subcutaneous administration.
    Van Den Berg W; Leferink JG; Kreukniet J; Bruynzeel PL
    Ann Allergy; 1980 Apr; 44(4):235-9. PubMed ID: 6245600
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dynamics of the lymphocyte beta-adrenoceptor system in patients with allergic bronchial asthma.
    Meurs H; Koëter GH; de Vries K; Kauffman HF
    Eur J Respir Dis Suppl; 1984; 135():47-61. PubMed ID: 6329809
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Addition of transdermal or inhaled long-acting Beta2-agonists in adult asthmatic patients treated with inhaled corticosteroids: switchover study from tulobuterol patch to salmeterol dry powder inhaler.
    Kobayashi Y; Yasuba H; Kudou M; Kita H
    J Asthma; 2007 Mar; 44(2):77-81. PubMed ID: 17454319
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sources of human plasma cyclic AMP. Examinations before and after beta 2 adrenergic stimulation.
    Endres P; Klock C; Günther R
    J Int Med Res; 1981; 9(6):521-5. PubMed ID: 6119267
    [No Abstract]   [Full Text] [Related]  

  • 40. [Beta-adrenergic receptor in bronchial asthma. Part 2. Human placental beta-adrenergic receptor in normal and asthmatic subjects].
    Sunaga Y; Yoshie Y; Nemoto T
    Arerugi; 1985 Feb; 34(2):88-95. PubMed ID: 2992425
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.